CRANBURY, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) — Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”),…
Continued enrollment of EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Announced…
NX-13 Demonstrated Favorable Safety and Tolerability Profile Across Range of Once-Daily Doses Results Indicate Promising…
Issuance Extends Nyxol’s U.S. Patent Protection from 2034 into 2039 for RM Indication Growing Patent…
Second Quarter Total Net Revenue of $37.0 Million MACI Net Revenue of $28.6 Million Conference…
§ Lesion swab (standard of care) and saliva-based sample collection planned § Peer-reviewed publication demonstrating saliva testing…
TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its…
– ARCALYST® (rilonacept) net revenue of $27.0 million in Q2 2022 – – ARCALYST full-year…
Brings Total Capital Raised Since December 2021 to $54.5 Million IRVINE, Calif., Aug. 03, 2022…
Prescription Drug User Fee Act (PDUFA) target date of January 1, 2023 YAVNE, Israel, Aug….
– Kiniksa to receive $100 million in upfront and near-term payments – – Kiniksa is…
Issued Claims for Single-Chain Chimeric Polypeptide and Composition Claims for Lead Product Candidate, HCW9302 MIRAMAR, Fla.,…
ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”)…
Investor call and webcast scheduled for Monday, August 15 at 8:00 a.m. EDT Roivant will…
– First patient dosed in the Phase 2 DAVIO 2 clinical trial for wet age-related macular…
– SRF388 clinical data presented at 2022 ASCO Annual Meeting demonstrated monotherapy responses in two…
NEW YORK and SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq:…
Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET RAMSEY, N.J. and BOCA…
WALTHAM, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…